HDAC9 and glioblastoma: In the current study, we also found that the combination of HDAC inhibitor panobinsotat with BET inhibitor JQ1 or OTX015 results in stronger repression of GBM-associated oncogenic genes or pathways as well as higher induction of GBM-associated tumor-suppressive genes.